Table 2.
Adverse event | Prevalence | Ref. |
GI complaints | 1%-17% | [16,17,19,20,37,38] |
Myelosuppression1 | 1%-15% | [17,20,36,38] |
General malaise | 4%-22% | [17,38] |
Allergic reaction | 1%-6% | [17,33] |
Other AE (e.g., myalgia, alopecia) | 1%-38% | [16,17,19,20,33,36-38] |
Variable definitions of myelosuppression were applied.